Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease
Tóm tắt
Serum reactivities towards individual U1 snRNP proteins were determined by immunoblotting in 32 patients with mixed connective tissue disease (MCTD). Time persistence of immunoblot profiles and clinical significance of anti-(U1)RNP antibody specificities were also investigated. IgG anti-(U1)RNP antibodies were found in the sera of 29 out of 32 patients (90.6%): 21 (65.6%) reacted with the 70-kD protein, 25 (78.1%) with A, 23 (71.9%) with C and 20 (62.5%) with B/B' proteins. None were reactive with the Sm-D peptide. Seventy kilodalton antibody specificity was strongly associated with a higher antinuclear antibody titre (>160) and slightly associated with disease activity; anti-B/B′ specificity was associated with lymphadenopathy. Anti-A, -C and -B/B′ antibodies were negatively associated with systemic lupus erythematosus (SLE) skin rashes. Two types of anti-(UI)RNP blotting patterns were selected: “full spectrum” (53.1% of cases) and a “partially/no reactive” one (46.9%). Such patterns were unchanged over time in 14 out of 16 cases prospectively examined (87.5%), while the pattern shifted from “full spectrum” to “partially/no reactive” in 2 cases (12.5%): in 1 after a prolonged clinical remission (≥4 years) and in the other following immunosuppressive therapy. The anti-(U1)RNP antibody immunoblot profile in MCTD patients consisted of various reactivities and remained unchanged over time in most cases. Antibody reactivity against the 70-kD protein represented the major Ul snRNP specificity. The various anti-(U1)RNP specific reactivities demonstrated poor clinical significance within MCTD. Thus, MCTD seems to be characterized by a longstanding serological heterogeneity whose reactivities do not apparently correspond to distinct features within the broad clinical spectrum of MCTD.
Tài liệu tham khảo
Lerner MR, Steitz JA (1979) Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 76:5495–5499
White PJ, Gardner WD, Hoch SO (1981) Identification of the immunologically active components of the Sm and RNP antigens. Proc Natl Acad Sci USA 78:626–630
Pettersson I, Hinterberger M, Mimori T, Gottlieb E, Steitz JA (1984) The structure of mammalian small nuclear ribonucleoproteins: identification of multiple protein components reactive with anti-(U) ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem 259:5907–5914
Van Venrooij WJ, Sillekens PTG (1989) Small nuclear RNA associated proteins: autoantigens in connective tissue diseases. Clin Exp Rheumatol 7:635–645
Pettersson I, Wang G, Smith EI, Wigzell H, Hedfors E, Horn J, Sharp GC (1986) The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. A cross-sectional, longitudinal study. Arthritis Rheum 29:986–996
Sharp GC, Irvin WS, Tan EM, Gould RG, Holmann HR (1972) Mixed connective tissue disease. An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159
Reichlin M (1993) Introduction to systemic rheumatic diseases: nosology and overlap syndromes. In: McCarty DJ, Koopman WJ (eds) Arthritis and allied conditions. Lea and Febiger, USA, pp 1149–1154
Habets WJ, De Rooij DJ, Salden MH, Verhagen AP, Van Eekelen CA, Van De Putte LB, Van Venrooij WJ (1983) Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clin Exp Immunol 54:265–276
Takeda Y, Wang GS, Wang RJ, Anderson SK, Pettersson I, Amaki S, Sharp GC (1989) Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides. Clin Immunol Immunopathol 50:213–230
Combe B, Rucheton M, Graafland H, Lussiez V, Brunel C, Sany J (1989) Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases. Clin Exp Immunol 75:18–24
McHugh N, James I, Maddison P (1990) Clinical significance of antibodies to a 68 kD Ul RNP polypeptide in connective tissue disease. J Rheumatol 17:1320–1328
Hoffman RW, Rettenmaier LJ, Takeda Y, Hewett JE, Pettersson I, Nyman U, Luger AM, Sharp GC (1990) Human autoantibodies against the 70-kd polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients. Arthritis Rheum 33:666–673
Kuwana M, Okano Y, Kaburaki J, Tsuji K, Inoko H (1995) Major histocompatibility complex class II gene associations with anti-U1 small nuclear ribonucleoprotein antibody. Arthritis Rheum 38:396–405
Kasukawa R, Tojo T, Miyawaki S, Yishida H, Tanimoto K, Nobunaga M, Suzuki T, Takasaki Y, Tamura T (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and anti-nuclear antibodies. Elsevier, Amsterdam, pp 41–47
Cotes JE (1979) Lung function. Blackwell Scientific, Oxford
Doria A, Bonavina L, Anselmino M, Ruffatti A, Favaretto M, Gambari PF, Peracchia A, Todesco S (1991) Esophageal involvement in mixed connective tissue disease. J Rheumatol 18:685–690
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 13:344–407
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Green Shaller J, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 227:680–685
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354
Bunn CC, Gharavi AE, Hughes GRV (1982) Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleo protein and Sm antigens observed by counterimmunoelectrophoresis. J Clin Lab Immunol 8:13–17
Doria A, Ghirardello A, de Zambiasi P, Ruffatti A, Gambari PF (1991) Japanese diagnostic criteria for mixed connective tissue disease in caucasian patients. J Rheumatol 19:259–264
Alarcon-Segovia D, Cardiel MD (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328–334
Sharp GC (1987) Diagnostic criteria for classification of MCTD. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and anti-nuclear antibodies. Elsevier, Amsterdam, pp 23–32
Alarcon-Segovia D, Villarreal M (1987) Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and anti-nuclear antibodies. Elsevier, Amsterdam, pp 33–40
Vencovsky J, Williams DG, Rield M, Maini RN (1992) Clinical associations of IgG antibodies to the ribonucleoprotein p67 polypeptide in patients with systemic lupus erythematosus. Ann Rheum Dis 51:1313–1317
Nyman U, Lundberg I, Hedfors E, Wahren M, Pettersson I (1992) IgG and IgM anti-snRNP reactivity in sequentially obtained serum samples from patients with connective tissue diseases. Ann Rheum Dis 51:1307–1312
Lundberg I, Nyman U, Pettersson I, Hedfors E (1992) Clinical manifestations and anti-(U1)snRNP antibodies; a prospective study of 29 anti-RNP antibody positive patients. Br J Rheumatol 31:811–817
Habets WJ, Berden JHM, Hoch SO, Van Venrooij WJ (1985) Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens. Eur J Immunol 15:992–997
Mimori T, Ogasawara T (1987) The structure and antigenic epitopes of Ul small nuclear ribonucleoprotein. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue disease and antinuclear antibodies. Elsevier, Amsterdam, pp 169–174
de Rooij GJRAM, Habets WJ, van de Putte LBA, Hoet MH, Verbeck AL, van Venrooij WJ (1990) Use of recombinant RNP peptides 70 kD and A in an ELISA for measurement of antibodies in mixed connective tissue disease: a longitudinal follow-up of 18 patients. Ann Rheum Dis 49:391–395
Nyman U, Lundberg I, Hedfors E, Pettersson I (1990) Recombinant 70 kD protein used for determination of autoantigenic epitopes recognized by anti-RNP sera. Clin Exp Immunol 81:52–58